Increased carbonic anhydrase activity in Friend erythroleukemia cells during DMSO-stimulated erythroid differentiation and its inhibition by BrdU.
Carbonic anhydrase activity is increased in Friend erythroleukemia (FL) cells during the enhancement of erythroid differentiation in the presence of dimethylsulfoxide (DMSO) or butyric acid. Untreated FL cells show an increase in enzyme activity associated with logarithmic growth. The increase in the specific activity of carbonic anhydrase in the differentiating treated cells, however, appears to be due to at least two additional general mechanisms: (1) an induction of carbonic anhydrase paralleling the stimulation of hemoglobin synthesis and (2) the stability and/or retention of active carbonic anhydrase as compared to most of the other cell proteins. The stimulation of carbonic anhydrase activity in the treated cells is inhibited by 5-bromo-2'-deoxyuridine (BrdU). This is the first demonstration of BrdU inhibition of a DMSO induced product not directly related to hemoglobin.
D000086:Acetazolamide / Q000494:pharmacology; D001973:Bromodeoxyuridine / Q000494:pharmacology*; D002087:Butyrates / Q000494:pharmacology; D002256:Carbonic Anhydrases / Q000378:metabolism*; D002455:Cell Division; D002460:Cell Line; D004121:Dimethyl Sulfoxide / Q000494:pharmacology*; D004163:Diphosphoglyceric Acids / Q000378:metabolism; D004920:Erythropoiesis
D002087:Butyrates; D004163:Diphosphoglyceric Acids; D002256:Carbonic Anhydrases; D001973:Bromodeoxyuridine; D000086:Acetazolamide; D004121:Dimethyl Sulfoxide